Angiotensin II, type 2 receptor in the development of vesico-ureteric reflux

BJU International

Volumn 83, Issue 3, 1999, Pages 318-322

  Hohenfellner, K ^a,c   Hunley, T E ^b   Yerkes, E ^b   Habermehl, P ^a   Hohenfellner, R ^a   Kon, V ^b  

^a Department of Pediatrics ^*  (Germany)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

A 1332G transition; A1166C; AT1 receptor; AT2 receptor; Renin angiotensin system; Vesico ureteric reflux

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; MALE; MEGAURETER; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URETEROPELVIC JUNCTION OBSTRUCTION; VESICOURETERAL REFLUX;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GENOTYPE; HUMANS; INFANT; MALE; MUTATION; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; VESICO-URETERAL REFLUX;

EID: 0033035429     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1999.00923.x     Document Type: Article

References (32)

1. 1 Matsusaka T, Hymes JL, Ichikawa I. Angiotensin in progressive renal diseases: Theory and Practice. J Am Soc Nephrol 1996; 7: 2025-43
2. 2 Wolf G, Neilson EG. Angiotensin II as a renal growth factor. J Am Soc Nephrol 1996; 3: 1531-40
3. 3 Gomez RA, El-Dahr S, Chevalier RL. Pediatric Nephrology, 3rd edn. Oxford UK: Williams and Wilkins, 1994: 79-97
4. 4 Matsusaka T, Ichikawa I. Biological functions of angiotensin and its receptors. Annu Rev Physiol 1997; 59: 395-412
5. 5 Gomez RA, Norwood VF. Developmental consequences of the renin-angiotensin system. Am J Kidney Dis 1995; 26: 409-31
6. 6 Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci 1996; 93: 156-60
7. 7 Nagata M, Tanimoto K, Fukamizu A et al. Nephrogenesis and renovascular development in angiotensinogen-deficient mice. Lab Invest 1996; 75: 745-53
8. 8 Esther CR, Howard TE, Marino EM, Godard JM, Capecchi MR, Bernstein KE. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility. Lab Invest 1996; 74: 953-6
9. 9 Tsuchida S, Matsusaka T, Chen X et al. Murine double nullizygotes of angiotensin type 1A and 1B receptor genes have the same abnormal phenotypes as angiotensinogen nullizygotes and more. J Am Soc Nephrol 1997; 8: 309A
10. 10 Nishimura H, Yerkes E, Schulman M et al. The angiotensin type 2 receptor null mutant mice: A model of the diverse spectrum of congenital urinary tract anomalies in humans. J Am Soc Nephrol 1997; 8: 364A
11. 11 Yerkes E, Nishimura H, Hohenfellner K et al. Association between the angiotensin type 2 receptor genotype and congenital urinary tract anomalies in two independent cohorts. J Am Soc Nephrol 1997; 8: 397A
12. 12 Arant BS. Vesicoureteric reflux and renal injury. Am J Kidney Dis 1991; 17: 491-511
13. 13 Ichiki T, Herold CL, Kambayashi Y, Bardham S, Inagami T. Cloning of the cDNA and the genomic DNA of the angiotensin II type 2 receptor. Biochimica et Biophysica Acta 1994; 1189: 247-50
14. 14 Bonnardeaux A, Jeunemaitre X, Charru A et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension. Hypertension 1994; 24: 63-9
15. 15 International Reflux Study Committee. Medical versus surgical treatment of primary vesicoureteral reflux. Pediatrics 1981; 67: 392-400
16. 16 Vnencak-Jones CL, De Phillips JA III, Fen W. Use of polymerase chain reaction in detection of growth hormone gene deletions. J Clin Endoc Metab 1990; 70: 1550-3
17. 17 Hunley TE, Julian BA, Phillips JA III et al. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-7
18. 18 Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 910-3
19. 19 Nishimura H, Yerkes E, Hohenfellner K et al. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Moll Cell 1999: in press.
20. 20 Carpenter C, Honkanen AA, Mashimo H et al. Renal abnormalities in mutant mice. Nature 1996; 28: 292
21. 21 Niimura F, Labosky PA, Kakuchi J et al. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1995; 96: 2947-54
22. 22 Kakinuma Y, Fogo A, Inagami T, Ichikawa I. Intrarenal localization of angiotensin II type 1 receptor mRNA in the rat. Kidney Int 1993; 43: 1229-35
23. 23 Schuetz S, Le Moullec J-M, Corvol P, Gasc J-M. Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol 1996; 149: 2067-79
24. 24 Kakuchi J, Ichiki T, Kiyama S et al. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int 1995; 47: 140-7
25. 25 Hohenfellner K, Hunley TE, Schloemer C et al. Association between the Angiotensin Type 2 receptor (AT2) genotype and congenital anomalies of the kidney and urinary tract (CAKUT). Pediatr Res 1998; 4: 1812A
26. 26 Brock JW III, Adams MC, Hunley TE, Wada A, Truster L, Kon V. Potential risk factors with progressive renal damage in childhood urological diseases: the role of angiotensin-converting enzyme gene polymorphism. J Urol 1997; 158: 1308-11
27. 27 Devine CH. Embryologie des Urogenitaltraktes. In Hohenfellner R, Zingg EJ. Urologie in Klinik und Praxis, Bd II. Stuttgart: Thieme, 1983: 833-49
28. 28 Stephens FD, Smith ED, Hutson JM. In Congenital anomalies of the urinary and genital tracts. Oxford: Isis Medical Media 1996: 312-5
29. 29 Frohneberg DH, Thuroff JW, Riedmiller H. Posterior urethral valves: Theoretical considerations on embryological development. Eur Urol 1982; 8: 325-8
30. 30 Sanyanusin P, Schimmenti LA, McNoe LA et al. Mutation of the PAX2 gene in a family with optic nerve colobomas, renal anomalies and vesicoureteral reflux. Nature Gen 1995; 9: 358-63
31. 31 Eccles MR, Bailey RR, Abbott GD, Sullivan MJ. Unravelling the genetics of vesicoureteric reflux: a common familial disorder. Hum Mol Gen 1996; 5: 1425-9
32. 32 Ozen S, Alikasifoglu M, Tuncbilek E et al. Polymorphisms in angiotensin converting enzyme gene and reflux nephropathy: a genetic predisposition to scar formation? Nephrol Dial Transplant 1997; 9: 2031-3